Panacea Biotec settled up 5% at its upper circuit limit of Rs 183. The counter clocked a volume of 11,424 shares as against its two-week average trades of 19,885 shares.
__________________________________________________________________ (Updated 1042 hrs)
The stock opened at its 5% upper circuit of Rs 183 and is currently locked at this level. Over 10,072 shares have been traded on the counter so far, with 20,822 buy orders pending. The stock has soared 17% in the past week itself.
The company has bagged a three-year contract from Unicef for supplying its Easy-Five vaccine. The order is worth Rs 1,000 crore. The vaccine is used for immunising children against five diseases - Diptheria, Tetanus, Pertussis, Hepatitis B and Hemophilus Influenza.
Content Guide
